FDA Approved: MEKINIST — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved MEKINIST (trametinib) in its original application for unresectable or metastatic melanoma with BRAF V600E or V600K mutations (in combination with d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• MEKINIST (trametinib)

Snippet

ORIG AP for MEKINIST (TRAMETINIB)